NCT05706311 (PharmTool) is a NA clinical trial of Clinical Decision Support Tool (Moderate Risk) in Opioid Abuse, sponsored by University of Utah.

Who is sponsoring NCT05706311?

NCT05706311 is sponsored by University of Utah.

What drugs are being tested in NCT05706311?

Interventions in NCT05706311: Clinical Decision Support Tool (Moderate Risk), Clinical Decision Support Tool (High Risk), Standard of Care.

What condition does NCT05706311 study?

NCT05706311 studies Opioid Abuse, Prescription Opioid Abuse.

Is NCT05706311 still recruiting?

NCT05706311 is currently active, enrolled. Last updated 17 February 2026.

Last reviewed 2026-02-17 · How we verify

NCT05706311: PharmTool

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool

Active, enrolled NA Last updated 17 February 2026

What this trial tests

NA trial testing Clinical Decision Support Tool (Moderate Risk) in Opioid Abuse in 80 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

21 January 2025

Primary endpoint
15 May 2026

15 May 2026

Quick facts

Lead sponsor	University of Utah
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	80
Start date	21 January 2025
Primary completion	15 May 2026
Estimated completion	15 May 2026
Sites	2 locations across United States

Drugs / interventions tested

Clinical Decision Support Tool (Moderate Risk)
Clinical Decision Support Tool (High Risk)
Standard of Care

Conditions studied

Opioid Abuse — all drugs for Opioid Abuse →
Prescription Opioid Abuse — all drugs for Prescription Opioid Abuse →

Sponsor

University of Utah

Who can join

Eligibility, any sex, with Opioid Abuse or Prescription Opioid Abuse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This goal of this observational study is to develop and test the Opioid Risk Reduction Clinical Decision Support (ORRCDS) tool. The tool will be an opioid medication risk screener and decision support platform that will be used by pharmacists upon dispensing prescription opioid medication. Once the Opioid Risk Reduction has been developed, we will examine the impact of the ORRCDS within two divisions of a large chain retail pharmacy. Pharmacies will be randomized to using the Opioid Risk Reduction Clinical Decision Support (ORRCDS) tool or standard of care opioid dispensation. We hypothesize that patients at pharmacies randomized to the ORRCDS tool will be more likely to reduce their risk status to low or moderate compared to the patients at standard of care pharmacies.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

CTN-0138: adaptation, implementation, and cluster randomized trial of a Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool-a protocol paper.
Cochran GT, Brown JL, Yu Z, Gordon AJ, et al · · 2024 · PMID 39558203 · DOI 10.1186/s13722-024-00514-1

Verify or expand the search:

Other recruiting trials for Opioid Abuse

Currently open trials in the same condition.

NCT03773523 — Neuromodulation and Cognitive Training in Opioid Use Disorder · NA · recruiting

Other University of Utah trials

Trials by the same sponsor.

NCT07515755 — Supplemental Oxygen and Oxygen Desaturations in Colonoscopies · NA · not yet recruiting
NCT07225426 — Personalizing Financial Incentives · NA · recruiting
NCT06716411 — Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness · NA · recruiting
NCT07246538 — Positive Airway Pressure (PAP) System Evaluation in Volunteers · NA · not yet recruiting
NCT04208984 — Diversion Device With Breath Control · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05706311 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Utah
Last refreshed: 17 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05706311.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing